ReviewCurrent treatment options in oncology2022
Do Patients Benefit from a Trial of Corticosteroids at the End of Life?
Sriram Yennurajalingam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCurrent treatment options in oncology2022
Sriram Yennurajalingam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.